Company / Financials
DNA X, Inc. Financials
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$93.6M
FY2024 · +34.1% YoY
Net Income
-$90.0K
FY2024 · +99.4% YoY
Profit Margin
-0.1%
FY2024 · net income / revenue
ROE
-0.4%
FY2024 · return on equity
Total Assets
$39.7M
FY2024
Total Debt
-
FY2024
Equity
$22.4M
FY2024
ROA
-0.2%
FY2024 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$93.6M+34.1% YoYNet Income HistoryProfit after all expenses and taxes-$90.0K+99.4% YoYGross Profit HistoryRevenue minus cost of goods sold$19.3M+66.3% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$74.3M+27.7% YoYOperating Income HistoryProfit from core business operations before interest and taxes$513.0K+103.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$8.3M-22.5% YoYR&D Expense HistoryResearch and development spending$1.8M-77.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$97.0KIncome Tax HistoryTotal income tax expense$374.0K+103.3% YoYEPS (Basic) HistoryBasic earnings per share-$0.02+95.9% YoY